Previous Article | Next Article ![]()
Infect. Immun., 02 1997, 718-728, Vol 65, No. 2
T Belay, R Cherniak, TR Kozel and A Casadevall
Cryptococcus neoformans glucuronoxylomannans (GXM) are capsular
polysaccharides important for virulence in cryptococcosis. This study used
dot enzyme assays (DEA) and enzyme-linked immunosorbent assays (ELISA) to
determine the reactivity patterns of 21 murine monoclonal antibodies (MAbs)
with structurally defined GXMs from five serotypes. The MAbs were
categorized into eight groups on the basis of DEA and five groups on the
basis of ELISA. MAbs 302, 339, and 439 were studied extensively for their
binding to various native and chemically modified GXMs. Quantitative
variation in the inhibitory effects of GXMs on the binding of MAbs 302,
339, and 439 were observed by competitive ELISA. O- Deacetylation of
serotype A, B, and D GXM resulted in the complete loss of their inhibitory
properties. Carboxyl group reduction of GXMs from serotypes A and D
resulted in a significant decrease of inhibitory activity for MAb.
Xylomannans and methyl glycosides exhibited no detectable inhibitory
activity on MAb binding to GXM. The results indicate (i) the existence of
five to eight MAb-defined distinct epitopes in C. neoformans GXM that can
elicit antibody responses, (ii) MAb detection of antigenic variation within
GXMs assigned to a particular serotype, (iii) good correspondence between
the patterns of MAb reactivities and polyclonal rabbit factor sera, (iv)
good agreement between MAb molecular structure and serotype reactivity, and
(v) a dependence of the serotype reactivity profile for a given MAb on the
technique used to measure binding.
Copyright © 1997, American Society for Microbiology
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay
Department of Chemistry, LBCS, Georgia State University, Atlanta 30303, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|